vs
Arcutis Biotherapeutics, Inc.（ARQT）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
Rocket Lab Corp的季度营收约是Arcutis Biotherapeutics, Inc.的1.4倍（$179.7M vs $129.5M），Arcutis Biotherapeutics, Inc.净利率更高（13.4% vs -29.5%，领先42.9%），Arcutis Biotherapeutics, Inc.同比增速更快（81.5% vs 35.7%），过去两年Arcutis Biotherapeutics, Inc.的营收复合增速更高（61.6% vs 39.2%）
Arcutis Biotherapeutics是一家临床阶段生物制药企业，专注于开发和商业化免疫介导皮肤病领域的创新处方疗法，产品管线覆盖银屑病、特应性皮炎、斑秃等适应症，主要服务美国市场的患者及医疗服务提供者，填补皮肤科诊疗领域的未满足需求。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
ARQT vs RKLB — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $129.5M | $179.7M |
| 净利润 | $17.4M | $-52.9M |
| 毛利率 | 91.0% | 38.0% |
| 营业利润率 | 14.2% | -28.4% |
| 净利率 | 13.4% | -29.5% |
| 营收同比 | 81.5% | 35.7% |
| 净利润同比 | 261.2% | -1.1% |
| 每股收益（稀释后） | $0.14 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $129.5M | $179.7M | ||
| Q3 25 | $99.2M | $155.1M | ||
| Q2 25 | $81.5M | $144.5M | ||
| Q1 25 | $65.8M | $122.6M | ||
| Q4 24 | $71.4M | $132.4M | ||
| Q3 24 | $44.8M | $104.8M | ||
| Q2 24 | $30.9M | $106.3M | ||
| Q1 24 | $49.6M | $92.8M |
| Q4 25 | $17.4M | $-52.9M | ||
| Q3 25 | $7.4M | $-18.3M | ||
| Q2 25 | $-15.9M | $-66.4M | ||
| Q1 25 | $-25.1M | $-60.6M | ||
| Q4 24 | $-10.8M | $-52.3M | ||
| Q3 24 | $-41.5M | $-51.9M | ||
| Q2 24 | $-52.3M | $-41.6M | ||
| Q1 24 | $-35.4M | $-44.3M |
| Q4 25 | 91.0% | 38.0% | ||
| Q3 25 | 91.2% | 37.0% | ||
| Q2 25 | 90.8% | 32.1% | ||
| Q1 25 | 86.6% | 28.8% | ||
| Q4 24 | 90.3% | 27.8% | ||
| Q3 24 | 87.7% | 26.7% | ||
| Q2 24 | 88.8% | 25.6% | ||
| Q1 24 | 93.4% | 26.1% |
| Q4 25 | 14.2% | -28.4% | ||
| Q3 25 | 8.6% | -38.0% | ||
| Q2 25 | -17.9% | -41.3% | ||
| Q1 25 | -37.3% | -48.3% | ||
| Q4 24 | -10.7% | -38.9% | ||
| Q3 24 | -87.3% | -49.5% | ||
| Q2 24 | -162.3% | -40.7% | ||
| Q1 24 | -63.8% | -46.4% |
| Q4 25 | 13.4% | -29.5% | ||
| Q3 25 | 7.5% | -11.8% | ||
| Q2 25 | -19.5% | -46.0% | ||
| Q1 25 | -38.1% | -49.5% | ||
| Q4 24 | -15.1% | -39.5% | ||
| Q3 24 | -92.8% | -49.6% | ||
| Q2 24 | -169.6% | -39.2% | ||
| Q1 24 | -71.4% | -47.7% |
| Q4 25 | $0.14 | $-0.09 | ||
| Q3 25 | $0.06 | $-0.03 | ||
| Q2 25 | $-0.13 | $-0.13 | ||
| Q1 25 | $-0.20 | $-0.12 | ||
| Q4 24 | $-0.09 | $-0.11 | ||
| Q3 24 | $-0.33 | $-0.10 | ||
| Q2 24 | $-0.42 | $-0.08 | ||
| Q1 24 | $-0.32 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.9M | $1.0B |
| 总债务越低越好 | $109.0M | $152.4M |
| 股东权益账面价值 | $189.5M | $1.7B |
| 总资产 | $433.0M | $2.3B |
| 负债/权益比越低杠杆越低 | 0.58× | 0.09× |
8季度趋势，按日历期对齐
| Q4 25 | $42.9M | $1.0B | ||
| Q3 25 | $47.1M | $976.7M | ||
| Q2 25 | $72.7M | $688.1M | ||
| Q1 25 | $53.1M | $428.4M | ||
| Q4 24 | $71.3M | $419.0M | ||
| Q3 24 | $134.9M | $442.4M | ||
| Q2 24 | $84.3M | $496.8M | ||
| Q1 24 | $190.1M | $492.5M |
| Q4 25 | $109.0M | $152.4M | ||
| Q3 25 | $108.5M | $347.0M | ||
| Q2 25 | $108.0M | $346.5M | ||
| Q1 25 | $107.6M | $345.9M | ||
| Q4 24 | $107.2M | $345.4M | ||
| Q3 24 | $204.6M | $61.2M | ||
| Q2 24 | $203.8M | $64.2M | ||
| Q1 24 | $202.8M | $66.8M |
| Q4 25 | $189.5M | $1.7B | ||
| Q3 25 | $158.1M | $1.3B | ||
| Q2 25 | $139.0M | $688.5M | ||
| Q1 25 | $142.7M | $431.3M | ||
| Q4 24 | $157.5M | $382.5M | ||
| Q3 24 | $156.6M | $419.8M | ||
| Q2 24 | $186.4M | $455.2M | ||
| Q1 24 | $224.9M | $478.9M |
| Q4 25 | $433.0M | $2.3B | ||
| Q3 25 | $371.0M | $2.2B | ||
| Q2 25 | $352.4M | $1.6B | ||
| Q1 25 | $344.1M | $1.3B | ||
| Q4 24 | $348.9M | $1.2B | ||
| Q3 24 | $437.4M | $1.2B | ||
| Q2 24 | $444.8M | $1.2B | ||
| Q1 24 | $478.5M | $1.2B |
| Q4 25 | 0.58× | 0.09× | ||
| Q3 25 | 0.69× | 0.27× | ||
| Q2 25 | 0.78× | 0.50× | ||
| Q1 25 | 0.75× | 0.80× | ||
| Q4 24 | 0.68× | 0.90× | ||
| Q3 24 | 1.31× | 0.15× | ||
| Q2 24 | 1.09× | 0.14× | ||
| Q1 24 | 0.90× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.2M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-114.2M |
| 自由现金流率自由现金流/营收 | — | -63.6% |
| 资本支出强度资本支出/营收 | 0.0% | 27.6% |
| 现金转化率经营现金流/净利润 | 1.51× | — |
| 过去12个月自由现金流最近4个季度 | — | $-321.8M |
8季度趋势，按日历期对齐
| Q4 25 | $26.2M | $-64.5M | ||
| Q3 25 | $-1.8M | $-23.5M | ||
| Q2 25 | $324.0K | $-23.2M | ||
| Q1 25 | $-30.4M | $-54.2M | ||
| Q4 24 | $-748.0K | $-2.4M | ||
| Q3 24 | $-34.7M | $-30.9M | ||
| Q2 24 | $-45.1M | $-13.0M | ||
| Q1 24 | $-31.6M | $-2.6M |
| Q4 25 | — | $-114.2M | ||
| Q3 25 | — | $-69.4M | ||
| Q2 25 | $246.0K | $-55.3M | ||
| Q1 25 | $-31.0M | $-82.9M | ||
| Q4 24 | — | $-23.9M | ||
| Q3 24 | $-34.8M | $-41.9M | ||
| Q2 24 | — | $-28.3M | ||
| Q1 24 | — | $-21.8M |
| Q4 25 | — | -63.6% | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | 0.3% | -38.3% | ||
| Q1 25 | -47.1% | -67.6% | ||
| Q4 24 | — | -18.1% | ||
| Q3 24 | -77.8% | -40.0% | ||
| Q2 24 | — | -26.7% | ||
| Q1 24 | — | -23.5% |
| Q4 25 | 0.0% | 27.6% | ||
| Q3 25 | 0.0% | 29.6% | ||
| Q2 25 | 0.1% | 22.2% | ||
| Q1 25 | 0.9% | 23.4% | ||
| Q4 24 | 0.0% | 16.3% | ||
| Q3 24 | 0.3% | 10.5% | ||
| Q2 24 | 0.0% | 14.4% | ||
| Q1 24 | 0.0% | 20.7% |
| Q4 25 | 1.51× | — | ||
| Q3 25 | -0.24× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARQT
暂无分部数据
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
